Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
SB3-G31-BC : Essai de phase 3 randomisé, en double aveugle, évaluant l’efficacité, la tolérance, la pharmacocinétique et l’immunogénicité du SB3 (proche du trastuzumab) et du trastuzumab (Herceptine®), chez des patientes ayant un cancer du sein HER2+. [essai clos aux inclusions] https://kusajili.fr:443/Trial/rCwlWzn7nUq6amoxTXzdmA%24sb3-g31-bc-essai-de-phase-3-randomise-en-double-aveugle-evaluant-lefficacite-la-tolerance-la-pharmacocinetique-et-limmunogenici
I have read and accept the terms of use of the site and the Privacy Policy
Send your message